Valence ロゴ
人気
ログイン

ウォッチリストに追加

First Trust NYSE Arca Bio...

NYSEArca: FBT · リアルタイム株価 · USD
260.74
+1.11 (0.43%)
終値時点： Aug 18, 2026, 3:56 PM

First Trust NYSE Arca Biotechnology Index Fund (FBT) Stock Price, Analysis & Data

0.43%
買気配n/a
時価総額n/a
売上高（TTM）n/a
純利益（TTM）n/a
ベータn/a
EPS（TTM）n/a
PER（TTM）27.97
予想PERn/a
PBR（TTM）1.51
PSR（TTM）n/a
Earnings Daten/a
売気配n/a
出来高22,300
平均出来高（20日）66,058
始値260.03
前日終値259.63
当日レンジ260.44 - 261.74
52週レンジ171.00 - 261.74
アナリストn/a
目標株価n/a
配当n/a
権利落ち日n/a

FBTについて

The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of 30 leading biotechnology companies....

[続きを読む]
業種 n/a
セクター n/a
IPO日 Jun 23, 2006
従業員数 n/a
上場取引所 NYSEArca
ティッカー FBT
企業情報の全文

業績

undefined年のFirst Trust NYSE Arca Biotechnology Index Fundの売上高はn/aで、前年のn/aからundefined%の増加でした。 利益はn/aで、undefined%の増加でした。

財務諸表
news image

3週間前 · 24/7 Wall St.

FBT and IBB Are Not the Same Biotech Bet, and 5 Years of Returns Prove It

Most biotech investors treat FBT and IBB as two names for the same trade, but the structural differences buried in their index methodologies have produced shockingly different outcomes depending on wh...

news image

1か月前 · Zacks

Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?

Smart Beta ETF report for FBT

news image

1か月前 · Zacks

Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?

Sector ETF report for FBT

news image

7か月前 · 24/7 Wall St.

Biotech Could Be One of 2026’s Biggest Winners, and This ETF Is Perfectly Positioned

Biotech investors spent years waiting for the sector to recover from its brutal 2021 peak. That patience is finally paying off. First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) has surged...

news image

9か月前 · Zacks

Inside the Recent Strength in Biotech ETFs

Biotech strength is back, with IBB, PBE, FBT, CANC and HELX climbing as cheaper valuations, rate-cut hopes, FDA approvals and strong deal activity fuel biotech gains.

2ページ中1ページ